PhD Defense bt Vitor Kamada

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Wednesday April 26, 2017 - Thursday April 27, 2017
      2:00 pm - 3:59 pm
  • Location: Old CE Building, Room 204.
  • Phone:
  • URL:
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact
No contact information submitted.
Summaries

Summary Sentence: Innovation in the Biopharmaceutical Industry

Full Summary: No summary paragraph submitted.

 

Ph.D. Dissertation Defense

Vitor Kamada

 

Title: Innovation in the Biopharmaceutical Industry

Abstract:

Three aspects of the drug development process are little understood in the literature: 1) which type of organization has comparative advantage in conducting clinical trials, firms or nonprofit organization (NPOs)?; 2) what determines the timing of technological collaboration, a step usually far away from drug commercialization?; and 3) how the strategies making, allying, and buying R&D impact the probability of drug approval? Using data on over 20,000 clinical trials, 800 technological alliances, and 14,000 R&D projects, the main findings of this econometric study are: 1) firms complete each phase of clinical trial faster than nonprofit organizations; 2) licensor scientific and technological specialization is the main factor to speed up the technological collaboration; and 3) R&D projects developed by research alliance have higher probability of drug approval than internal R&D projects, but R&D projects originated from M&A have lower probability of drug approval than internal R&D projects. Together these findings inform policy makers and managers on how to foster the innovation performance in the biopharmaceutical industry.

 

Committee:

Dr. Usha Nair-Reichert, Chair, Advisor, School of Economics -Georgia Institute of Technology

Dr. Levent Kutlu, School of Economics -Georgia Institute of Technology / Antalya International University

Dr. Patrick S. McCarthy, School of Economics -Georgia Institute of Technology

Dr. Mikhail Klimenko, School of Economics -Georgia Institute of Technology

Dr.  Richard Barke, School of Public Policy -Georgia Institute of Technology

 

Date/Time:

Wednesday, April 26, 2017, 2:00 to 3:30 pm.

Location:

Old CE Building, Room 204.

Additional Information

In Campus Calendar
No
Groups

Graduate Studies

Invited Audience
Public
Categories
Other/Miscellaneous
Keywords
Phd Defense
Status
  • Created By: Tatianna Richardson
  • Workflow Status: Published
  • Created On: Apr 7, 2017 - 4:47pm
  • Last Updated: Apr 7, 2017 - 4:49pm